Skip to content

Agios Pharmaceuticals

US · AGIO #2841 by market cap Listed 1970
27.60 -1.16 -4.03%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: RBC Capital moved from Buy to Hold on 2026-02-12.

Analyst consensus 6 analysts

Buy
Avg price target 45.80 +65.9%
Price target rangecurrent 27.60
Low32.00
Avg45.80
High62.00
Buy 67% Hold 33% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-06 BofA Securities -- Buy 48.00
2026-11-06 Truist Financial -- Buy 35.00
2026-11-06 H.C. Wainwright -- Buy 62.00
2026-11-05 Truist Financial -- Buy 35.00
2026-11-05 H.C. Wainwright -- Buy 55.00
2026-11-05 RBC Capital -- Hold 32.00
2026-11-02 H.C. Wainwright -- Buy 55.00
2026-10-31 J.P. Morgan -- Hold --
2026-10-30 BofA Securities -- Buy 50.00
2026-10-30 H.C. Wainwright -- Buy 55.00
2026-10-29 H.C. Wainwright -- Buy 55.00
2026-10-28 Citi -- Buy 52.00
2026-10-08 RBC Capital -- Hold 32.00
2026-10-07 Truist Financial -- Buy 37.00
2026-10-06 BofA Securities -- Buy 50.00
2026-09-21 BofA Securities -- Buy 50.00
2026-08-11 Truist Financial -- Buy --
2026-08-03 TD Cowen -- Buy --
2026-07-31 Truist Financial -- Buy 39.00
2026-07-31 Citi -- Buy 52.00
2026-07-30 TD Cowen -- Buy --
2026-07-30 BofA Securities -- Buy 46.00
2026-07-30 Citi -- Buy 52.00
2026-07-30 H.C. Wainwright -- Buy 55.00
2026-07-22 BofA Securities -- Buy 46.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-02-12 RBC Capital Buy → Hold 28.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- ±9.00% -9.91% (beat)
2026/Q2 2026-07-30 -- ±9.54% -6.46% (in line)
2026/Q1 2026-04-29 -- ±8.47% +13.10% (beat)
2025/Q4 2026-02-12 -- ±12.45% +1.30% (in line)
2025/Q3 2025-10-30 -- ±16.58% +2.91% (in line)
2025/Q2 2025-07-31 -- ±11.40% -0.85% (in line)
2025/Q1 2025-05-01 -- ±21.61% +4.21% (in line)
2024/Q4 2025-02-13 -- ±8.31% +1.49% (in line)
2024/Q3 2024-10-31 -- ±15.71% -4.04% (in line)
2024/Q2 2024-08-01 -- ±13.46% -4.09% (in line)
2024/Q1 2024-05-02 -- ±13.65% +2.73% (in line)
2023/Q4 2024-02-15 -- ±8.96% +3.47% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Agios Pharmaceuticals discussion 0 comments

Add a comment